BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guo CY, Wu YB, Liu HL, Wu JY, Zhong MZ. Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. World J Gastroenterol 2004; 10(5): 747-749 [PMID: 14991953 DOI: 10.3748/wjg.v10.i5.747]
URL: https://www.wjgnet.com/1007-9327/full/v10/i5/747.htm
Number Citing Articles
1
Ying-Qun Zhou, Ling Xu, Bing-Fang Wang, Xiao-Ming Fan, Jian-Ye Wu, Chun-Yan Wang, Chuan-Yong Guo, Xuan-Fu Xu. Modified Sequential Therapy Regimen versus Conventional Triple Therapy forHelicobacter pyloriEradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative StudyGastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/405425
2
Samson Cantu, Mark A. Gilger. Feigin and Cherry's Textbook of Pediatric Infectious Diseases2009; : 1765 doi: 10.1016/B978-1-4160-4044-6.50152-7
3
Tao Wu, Lichen Wang, Meiliang Gong, Yunjuan Lin, Yaping Xu, Ling Ye, Xiang Yu, Jing Liu, Jianwei Liu, Shuli He, Hao Zeng, Gangshi Wang. Synergistic effects of nanoparticle heating and amoxicillin on H. pylori inhibitionJournal of Magnetism and Magnetic Materials 2019; 485: 95 doi: 10.1016/j.jmmm.2019.04.076
4
Faezeh Kiani, Sara Khademolhosseini, Mobina Fathi, Arian Tavasol, Jasem Mohammadi, Majid Dousti, Jalal Eshagh Hoseini. Standard Triple Therapy as a Remedy for Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical TrialsCurrent Reviews in Clinical and Experimental Pharmacology 2023; 18(2): 167 doi: 10.2174/2772432817666220317152544
5
György M Buzás, Jolán Józan. Nitrofuran‐based regimens for the eradication of Helicobacter pylori infectionJournal of Gastroenterology and Hepatology 2007; 22(10): 1571 doi: 10.1111/j.1440-1746.2007.05082.x
6
Chao-ran Ji, Jing Liu, Yue-yue Li, Chuan-guo Guo, Jun-yan Qu, Yan Zhang, Xiuli Zuo. Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysisBMJ Open 2020; 10(10): e037375 doi: 10.1136/bmjopen-2020-037375
7
Faezeh Kiani, Sara Khademolhosseini, Jasem Mohammadi, Arian Tavasol, Ramtin Hajibeygi, Mobina Fathi, Majid Dousti. Novel Information Regarding the Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical TrialsCurrent Reviews in Clinical and Experimental Pharmacology 2024; 19(2): 184 doi: 10.2174/2772432818666230120111237
8
Ben Wang, Zhi-Fa Lv, You-Hua Wang, Hui Wang, Xiao-Qun Liu, Yong Xie, Xiao-Jiang Zhou. Standard triple therapy for <italic>Helicobacter pylori</italic> infection in China: A meta-analysisWorld Journal of Gastroenterology 2014; 20(40): 14973-14985 doi: 10.3748/wjg.v20.i40.14973
9
Quan Zhou, Ling-Ling Zhu, Xiao-Feng Yan, Wen-Sheng Pan, Su Zeng. Drug utilization of clarithromycin for gastrointestinal disease treatmentWorld Journal of Gastroenterology 2008; 14(39): 6065-6071 doi: 10.3748/wjg.14.6065
10
Ying Ying Han, Ji Yan Li, Jia Lun Guan, Mei Liu, Pei Yuan Li. Application of furazolidone in Helicobacter pylori infection eradicationJournal of Digestive Diseases 2024; 25(3): 148 doi: 10.1111/1751-2980.13265
11
Naoki Chiba. Evidence‐Based Gastroenterology and Hepatology2010; : 102 doi: 10.1002/9781444314403.ch6
12
Eva C. Arrua, Sofía V. Sanchez, Valeria Trincado, Antonio Hidalgo, Andrew F.G. Quest, Javier O. Morales. Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pyloriColloids and Surfaces B: Biointerfaces 2022; 213: 112403 doi: 10.1016/j.colsurfb.2022.112403
13
Yong Xie, Zhenyu Zhang, Junbo Hong, Wenzhong Liu, Hong Lu, Yiqi Du, Weihong Wang, Jianming Xu, Xuehong Wang, Lijuan Huo, Guiying Zhang, Chunhui Lan, Xiaoyan Li, Yanqing Li, Hong Wang, Guoxin Zhang, Yin Zhu, Xu Shu, Ye Chen, Jiangbin Wang, Nonghua Lu. Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in ChinaHelicobacter 2018; 23(5) doi: 10.1111/hel.12496
14
Liya Zhuge, Youhua Wang, Shuang Wu, Ru‐Lin Zhao, Zhen Li, Yong Xie. Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta‐analysisHelicobacter 2018; 23(2) doi: 10.1111/hel.12468
15
A. A. NIJEVITCH, P. L. SHCHERBAKOV, V. U. SATAEV, R. SH. KHASANOV, R. AL KHASHASH, M. M. TUYGUNOV. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidoneAlimentary Pharmacology & Therapeutics 2005; 22(9): 881 doi: 10.1111/j.1365-2036.2005.02656.x
16
Fernando M Silva, Jaime N Eisig, Ana Cristina S Teixeira, Ricardo C Barbuti, Tomás Navarro-Rodriguez, Rejane Mattar. Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacyBMC Gastroenterology 2008; 8(1) doi: 10.1186/1471-230X-8-20
17
Min Luo, Yi-Yang Jia, Zi-Wei Jing, Chen Li, Si-Yuan Zhou, Qi-Bing Mei, Bang-Le Zhang. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pyloriColloids and Surfaces B: Biointerfaces 2018; 164: 11 doi: 10.1016/j.colsurfb.2018.01.008
18
Angelo Zullo, Cesare Hassan, Salvatore MA Campo, Sergio Morini. Evolving therapy for Helicobacter pylori infectionExpert Opinion on Therapeutic Patents 2004; 14(10): 1453 doi: 10.1517/13543776.14.10.1453
19
Yu-Hsin Lin, Jui-Hsiang Lin, Shen-Chieh Chou, Shu-Jen Chang, Chun-Chia Chung, Yueh-Sheng Chen, Chiung-Hung Chang. Berberine-Loaded Targeted Nanoparticles as Specific Helicobacter Pylori Eradication Therapy: In Vitro and In Vivo Study Nanomedicine 2015; 10(1): 57 doi: 10.2217/nnm.14.76
20
Conghua Song, Xing Qian, Yin Zhu, Xu Shu, Yanping Song, Zhijuan Xiong, Jianfang Ye, Tao Yu, Ling Ding, Hui Wang, Nonghua Lu, Yong Xie. Effectiveness and safety of furazolidone‐containing quadruple regimens in patients with Helicobacter pylori infection in real‐world practiceHelicobacter 2019; 24(4) doi: 10.1111/hel.12591
21
Karin Van Amsterdam, Arnoud H. M. Van Vliet, Johannes G. Kusters, Arie Van Der Ende. Of microbe and man: determinants ofHelicobacter pylori-related diseasesFEMS Microbiology Reviews 2006; 30(1): 131 doi: 10.1111/j.1574-6976.2005.00006.x
22
Johannes G. Kusters, Arnoud H. M. van Vliet, Ernst J. Kuipers. Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews 2006; 19(3): 449 doi: 10.1128/CMR.00054-05
23
Jiang Lin, Wei-Wen Huang. A systematic review of treating <italic>Helicobacter pylori</italic> infection with Traditional Chinese MedicineWorld Journal of Gastroenterology 2009; 15(37): 4715-4719 doi: 10.3748/wjg.15.4715
24
S. Turi, D. Schilling, J. F. Riemann. Eradikation und chronische S�ureblockadeDer Internist 2004; 45(11): 1305 doi: 10.1007/s00108-004-1237-0